ADXN — Addex Therapeutics Share News
0.000.00%
- CH₣5.17m
- CH₣3.56m
- CH₣0.17m
NASDAQ RESUMED AT 02:25 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:20 PM
NASDAQ RESUMED AT 02:19 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:07 PM
NASDAQ RESUMED AT 09:50 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM
Brief: Addex Therapeutics Provides Update On Dipraglurant Blepharospasm Phase 2 Feasibility Clinical Study
Baader cuts Addex Therapeutics on higher cash burn from trial delays
Europe Research Roundup: Centrica, Air Liquide, Voestalpine
Brief: Addex Therapeutics: Q1 Net Loss At CHF 5.8 Mln
Swiss stocks - Factors to watch on May 5
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
Brief: Addex Therapeutics Expands Pipeline For Treatment Of Schizophrenia & Other Psychotic Disorders
Swiss stocks - Factors to watch on January 10
Brief: Addex Therapeutics Files For Resale Of Up To 2.45 Mln American Depositary Shares By The Selling Shareholder
Brief: Addex Raises $10.0 Mln In Equity Financing
Brief: Addex Therapeutics Starts Phase 2 Clinical Study With Dipraglurant
Swiss stocks - Factors to watch on September 29